Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARNA | AMGN | VRTX | GILD | BMY |
| Company | Arena Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 99.97 | 322.00 | 493.70 | 94.00 | 55.19 |
| High | 100.00 | 322.97 | 504.31 | 98.32 | 55.51 |
| Low | 99.97 | 318.54 | 486.64 | 93.51 | 54.49 |
| Last | 99.99 | 321.91 | 502.45 | 97.90 | 54.71 |
| Change | +0.06 | +0.12 | +8.81 | +6.21 | -0.57 |
| % Change | +0.06% | +0.04% | +1.78% | +6.77% | -1.03% |
| Volume | 5,718,500 | 2,654,800 | 992,300 | 14,389,800 | 12,042,101 |
| 20-Day Average Volume | 1,676,465 | 1,833,545 | 1,100,485 | 5,818,440 | 9,045,295 |
| Previous Close | 99.93 | 321.79 | 493.64 | 91.69 | 55.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 94.81 | 319.73 | 481.51 | 88.46 | 53.47 |
| 20-Day Raw Stochastic | 99.86% | 60.84% | 90.35% | 97.03% | 61.93% |
| 20-Day Relative Strength | 75.07% | 50.79% | 60.67% | 81.85% | 58.42% |
| Weighted Alpha | -14.40 | +18.09 | +33.65 | +42.65 | +14.68 |
| Today's Opinion | 100% Buy | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 24% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 8% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.34% since 03/03/22 | +0.55% since 10/31/24 | +5.56% since 10/31/24 | +10.22% since 10/31/24 | -1.90% since 10/31/24 |
| Low | 93.54 on 03/07/22 | 313.02 on 11/05/24 | 463.14 on 11/01/24 | 88.19 on 11/01/24 | 54.20 on 11/01/24 |
| High | 100.00 on 03/10/22 | 325.39 on 11/06/24 | 506.65 on 11/06/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| 1-Month | |||||
| %Chg | +6.37% since 02/10/22 | +1.40% since 10/07/24 | +12.00% since 10/07/24 | +15.95% since 10/07/24 | +2.38% since 10/07/24 |
| Low | 92.85 on 02/22/22 | 310.63 on 10/30/24 | 451.11 on 10/08/24 | 84.17 on 10/11/24 | 51.31 on 10/15/24 |
| High | 100.00 on 03/10/22 | 329.17 on 10/11/24 | 506.65 on 11/06/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| 3-Month | |||||
| %Chg | +100.22% since 12/10/21 | +3.01% since 08/07/24 | +7.85% since 08/07/24 | +32.30% since 08/07/24 | +17.66% since 08/07/24 |
| Low | 89.03 on 01/25/22 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 100.00 on 03/10/22 | 339.17 on 09/23/24 | 506.65 on 11/06/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| 6-Month | |||||
| %Chg | +68.36% since 09/10/21 | +7.20% since 05/07/24 | +22.48% since 05/07/24 | +49.56% since 05/07/24 | +24.23% since 05/07/24 |
| Low | 48.12 on 12/06/21 | 295.30 on 06/13/24 | 412.12 on 05/08/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 100.00 on 03/10/22 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 98.32 on 11/07/24 | 56.80 on 11/06/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,165,283 | 172,972,768 | 127,409,472 | 114,153,312 | 112,117,616 |
| Shares Outstanding, K | 61,659 | 537,533 | 258,102 | 1,244,992 | 2,028,177 |
| Annual Sales | 50,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -616,430,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 50,000 | 8,503,000,000 | 2,645,600,000 | 6,954,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -155,610,000 | 2,830,000,000 | -3,593,600,000 | 1,614,000,000 | 1,211,000,000 |
| 60-Month Beta | 0.55 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.54 on 02/23/22 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 05/04/22 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 12/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 0.00 | 19.20 | 47.82 |